Is Part Of: Cancer letters. Volume 556(2023) - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Is Part Of Cancer letters. Volume 556(2023)

1. Editorial Board. (1st March 2023)

Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Interferon stimulated gene 15 (ISG15) in cancer: An update. (1st March 2023)

Authors:: Nguyen, Hong-My; Gaikwad, Shreyas; Oladejo, Mariam; Agrawal, Manas Yogendra; Srivastava, Sanjay K.; Wood, Laurence M.
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity. (1st March 2023)

Authors:: Jiang, Su; Feng, Ranran; Tian, Ziying; Zhou, Jieyu; Zhang, Wenling
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. (1st March 2023)

Authors:: Hegde, Mangala; Naliyadhara, Nikunj; Unnikrishnan, Jyothsna; Alqahtani, Mohammed S.; Abbas, Mohamed; Girisa, Sosmitha; Sethi, Gautam; Kunnumakkara, Ajaikumar B.
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment. (1st March 2023)

Authors:: Tang, Wenjiao; Xu, Juan; Xu, Caigang
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. (1st March 2023)

Authors:: Kleczko, Emily K.; Le, Anh T.; Hinz, Trista K.; Nguyen, Teresa T.; Navarro, Andre; Hu, Cheng-Jun; Selman, Ana M.; Clambey, Eric T.; Merrick, Daniel T.; Lu, Sizhao; Weiser-Evans, Mary; Nemenoff, Raphael A.; Heasley, Lynn E.
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Pericytes in the tumor microenvironment. (1st March 2023)

Authors:: Jiang, Zhongyi; Zhou, Jing; Li, Luohong; Liao, Shan; He, Junyu; Zhou, Shubo; Zhou, Yanhong
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. PROTACs: Promising approach for anticancer therapy. (1st March 2023)

Authors:: Kaur, Simran Deep; Bedi, Neena; Kumar, Deepak; Kapoor, Deepak N.
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma. (1st March 2023)

Authors:: Lin, Zhong-Zhe; Hu, Mickey C-T; Hsu, Chiun; Wu, Yao-Ming; Lu, Yen-Shen; Ho, Ja-An Annie; Yeh, Shiou-Hwei; Chen, Pei-Jer; Cheng, Ann-Lii
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer. (1st March 2023)

Authors:: Jiang, Wei; Ouyang, Xueyan; Ji, Zhaodong; Shi, Wanling; Wu, Yutuan; Yao, Qianlan; Wang, Yi; Yang, Wentao; Xiang, Libing; Yang, Huijuan
Journal:: Cancer letters
Issue:: Volume 556(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗